Instil Bio, Inc. (TIL)
5.51
-0.57
(-9.38%)
USD |
NASDAQ |
Nov 16, 15:24
Instil Bio Price to Book Value : 0.348 for Nov. 16, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 0.384 |
| November 12, 2026 | 0.3941 |
| November 11, 2026 | 0.3985 |
| November 10, 2026 | 0.4011 |
| November 09, 2026 | 0.4086 |
| November 06, 2026 | 0.4314 |
| November 05, 2026 | 0.4415 |
| November 04, 2026 | 0.4415 |
| November 03, 2026 | 0.4213 |
| November 02, 2026 | 0.4137 |
| October 30, 2026 | 0.4295 |
| October 29, 2026 | 0.4311 |
| October 28, 2026 | 0.4288 |
| October 27, 2026 | 0.3688 |
| October 26, 2026 | 0.3518 |
| October 23, 2026 | 0.3688 |
| October 22, 2026 | 0.36 |
| October 21, 2026 | 0.3644 |
| October 20, 2026 | 0.3752 |
| October 19, 2026 | 0.3657 |
| October 16, 2026 | 0.3733 |
| October 15, 2026 | 0.3872 |
| October 14, 2026 | 0.3758 |
| October 13, 2026 | 0.3903 |
| October 12, 2026 | 0.4156 |
| Date | Value |
|---|---|
| October 09, 2026 | 0.4257 |
| October 08, 2026 | 0.4143 |
| October 07, 2026 | 0.4358 |
| October 06, 2026 | 0.4348 |
| October 05, 2026 | 0.439 |
| October 02, 2026 | 0.456 |
| October 01, 2026 | 0.457 |
| September 30, 2026 | 0.4573 |
| September 29, 2026 | 0.451 |
| September 28, 2026 | 0.4446 |
| September 25, 2026 | 0.4528 |
| September 24, 2026 | 0.4497 |
| September 23, 2026 | 0.457 |
| September 22, 2026 | 0.4503 |
| September 21, 2026 | 0.4465 |
| September 18, 2026 | 0.4478 |
| September 17, 2026 | 0.4554 |
| September 16, 2026 | 0.4535 |
| September 15, 2026 | 0.4554 |
| September 14, 2026 | 0.4705 |
| September 11, 2026 | 0.4661 |
| September 10, 2026 | 0.4648 |
| September 09, 2026 | 0.4787 |
| September 08, 2026 | 0.4939 |
| September 04, 2026 | 0.4787 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.352 |
| Alnylam Pharmaceuticals, Inc. | 5.930 |
| Anika Therapeutics, Inc. | 1.265 |
| Savara, Inc. | 8.461 |
| Arrowhead Pharmaceuticals, Inc. | 125.50 |
Price to Book Value Related Metrics
| Price | 5.51 |
| Earnings Yield | -81.17% |
| Market Cap | 37.37M |